Share chart Esperion Therapeutics, Inc.
Extended chart
Simple chart
About Esperion Therapeutics, Inc.
Фармацевтическая компания Esperion Therapeutics, Inc. разрабатывает и продает лекарства для лечения пациентов с повышенным уровнем холестерина липопротеинов низкой плотности в США и за рубежом. Его основными кандидатами в продукты являются таблетки NEXLETOL (бемпедоевая кислота) и NEXLIZET (бемпедоевая кислота и эзетимиб) для лечения пациентов с атеросклеротическим сердечно-сосудистым заболеванием или гетерозиготной семейной гиперхолестеринемией. more details| IPO date | 2013-06-26 |
|---|---|
| ISIN | US29664W1053 |
| Industry | Biotechnology |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Див.доход ао | 0 |
| Сайт | https://www.esperion.com |
| Цена ао | 1.63 |
| Change price per day: | -2.98% (1.68) |
|---|---|
| Change price per week: | -2.4% (1.67) |
| Change price per month: | -10.44% (1.82) |
| Change price per 3 month: | -29.13% (2.3) |
| Change price per half year: | -0.6098% (1.64) |
| Change price per year: | -37.79% (2.62) |
| Change price per 3 year: | -71.3% (5.68) |
| Change price per 5 year: | -95.58% (36.89) |
| Change price per 10 year: | -97.3% (60.28) |
| Change price per year to date: | -24.19% (2.15) |
|
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
|||||||||||||||||||||||||||||||||||||
| Institutions | Volume | Share, % |
|---|---|---|
| Orbimed Advisors LLC. | 14 | 7.24 |
| Bellevue Group AG | 10 | 5.25 |
| Wasatch Advisors LP | 9 | 4.82 |
| Vanguard Group Inc | 9 | 4.66 |
| Great Point Partners LLC | 8 | 4.22 |
| Woodline Partners LP | 8 | 4.18 |
| Millennium Management LLC | 6 | 3 |
| Shaw D.E. & Co., Inc. | 5 | 2.71 |
| Bank of America Corporation | 5 | 2.4 |
| Two Seas Capital LP | 4 | 2.2 |
| ETF | Share, % | Profitability for 1 year, % | Dividends, % |
|---|---|---|---|
| Jacob Forward ETF | 3.54096 | 43.03 | 0.15284 |
| Virtus LifeSci Biotech Products ETF | 0.87132 | 36.79 | 0.13953 |
| ProShares UltraShort Nasdaq Biotechnology | 0.19 | -40.36 | 1.76 |
| iShares Micro-Cap ETF | 0.08058 | 17.09 | 1.54048 |
| Goldman Sachs ActiveBeta US Small Cap Equity ETF | 0.02335 | 31.36 | 1.41955 |
| Vanguard Russell 2000 Growth ETF | 0.01 | 23.05 | 0.60264 |
| Vanguard Russell 2000 ETF | 0.01 | 17.16 | 1.48801 |
ProShares UltraPro Russell2000
|
0.00686 | 89.82 | 1.47873 |
iShares Russell 2000 Growth ETF
|
0.0064 | 38.04 | 0.6026 |
| ProShares Hedge Replication ETF | 0.002 | 5.92 | 1.47892 |
| iShares Russell 3000 ETF | 0.00073 | 24.83 | 1.43482 |
| Avantis U.S. Equity ETF | 0.00054 | 23.04 | 1.59151 |
| Vanguard Russell 3000 ETF | 0 | 31.87 | 1.43817 |
| 0.36 | 26.28 | 1.16 |
| Head | Job title | Payment | Year of birth |
|---|---|---|---|
| Mr. Sheldon L. Koenig | President, CEO & Director | 1.2M | 1966 (59 years) |
| Mr. Eric J. Warren R.Ph. | Chief Commercial Officer | N/A | 1972 (53 years) |
| Ms. Betty Jean Swartz | Chief Business Officer | N/A | |
| Mr. Benjamin Halladay M.B.A. | Chief Financial Officer | N/A | 1986 (39 years) |
| Mr. Glenn P. Brame | Chief Technical Operations Officer | N/A | 1958 (67 years) |
| Tiffany Aldrich M.B.A. | Associate Director of Corporate Communications | N/A | |
| Mr. Benjamin O. Looker J.D. | General Counsel & Corporate Secretary | 1982 (43 years) |
Address: United States, Ann Arbor, MI , 3891 Ranchero Drive - open in Google maps, open in Yandex maps
Website: https://www.esperion.com
Website: https://www.esperion.com
